Abstract:Background: The GABRA1 gene, encoding the GABR A R subunit α1, plays vital roles in inhibitory neurons. Previously, the GABRA1 gene has been identified to be associated with developmental and epileptic encephalopathy (DEE) and idiopathic generalized epilepsy (IGE). This study aims to explore the phenotypic spectrum of GABRA1 and molecular subregional effect analysis. Methods: Trios-based whole-exome sequencing was performed in patients with epilepsy. Previously reported GABRA1 mutations were systematically reviewed to analyze the molecular subregional effects. Results: De novo GABRA1 mutations were identified in six unrelated patients with heterogeneous epilepsy, including three missense mutations (p.His83Asn, p.Val207Phe, and p.Arg214Cys) and one frameshift mutation (p.Thr453Hisfs*47). The two missense mutations, p.His83Asn and p.Val207Phe, were predicted to decrease the protein stability but no hydrogen bond alteration, with which the two patients also presented with mild genetic epilepsy with febrile seizures plus and achieved seizure-free status by monotherapy. The missense variant p.Arg214Cys was predicted to decrease protein stability and destroy hydrogen bonds with surrounding residues, which was recurrently identified in three cases with severe DEE. The frameshift variant p.Thr453Hisfs*47 was located in the last fifth residue of the C-terminus and caused an extension of 47 amino acids, with which the patients presented with moderated epilepsy with generalized tonic-clonic seizures alone (GTCA) but achieved seizure-free status by four drugs. The four variants were not presented in gnomAD and were evaluated as "pathogenic/likely pathogenic" according to ACMG criteria. Analysis of all reported cases indicated that patients with mutations in the N-terminal extracellular region presented a significantly higher percentage of FS and DEE, and the patients with variants in the transmembrane region presented earlier seizure onset ages. Significance: This study suggested that GABRA1 variants were potentially associated with a spectrum of epilepsies, including EFS+, DEE, and GTCA. Phenotypic severity may be associated with the damaging effect of variants. The molecular subregional effects help in understanding the underlying mechanism of phenotypic variation.

SETD1B Variants Associated with Absence Seizures

Clinical and Molecular Analysis of Epilepsy-Related Genes in Patients with Dravet Syndrome

De Novo and Inherited SETD1A Variants in Early-onset Epilepsy

Atypical absence seizures and gene variants: A gene-based review of etiology, electro-clinical features, and associated epilepsy syndrome

Phenotypes of autism spectrum disorder and schizoaffective disorder associated with SETD1B gene but without intellectual disability and seizures

<i>SZT2</i> variants associated with partial epilepsy or epileptic encephalopathy and the genotype-phenotype correlation

SCN1A-Related Epilepsy: Novel Mutations and Rare Phenotypes

Delineating the molecular and phenotypic spectrum of the SETD1B-related syndrome

Mental retardation, seizures and language delay caused by new SETD1B mutations: Three case reports

Case Report: A Compound Heterozygous Mutations in ASNS Broadens the Spectrum of Asparagine Synthetase Deficiency in the Prenatal Diagnosis

Novel variants of SYNGAP1 associated epileptic encephalopathy: two cases report and literature review

Genotypic and phenotypic characteristics of sodium channel-associated epilepsy in Chinese population

Genetic analysis of developmental and epileptic encephalopathy caused by novel biallelic SZT2 gene mutations in three Chinese Han infants: a case series and literature review

Epigenotype-genotype-phenotype Correlations in SETD1A and SETD2 Chromatin Disorders.

SYN1 variant causes X-linked neurodevelopmental disorders: a case report of variable clinical phenotypes in siblings

Mutations of schizophrenia risk gene SETD1A dysregulate synaptic function in human neurons

Exome Sequencing of 963 Chinese Families Identifies Novel Epilepsy Candidate Genes

Germline De Novo Variants in CSNK2B in Chinese Patients with Epilepsy.

De novo GABRA1 variants in childhood epilepsies and the molecular subregional effects

Common genes and recurrent causative variants in 957 Asian patients with pediatric epilepsy

An intractable epilepsy phenotype of ASNS novel mutation in two patients with asparagine synthase deficiency